​How many versions of Alpelisib are there?

Alpelisib for the treatment of PIK3CA-mutated HR/HER2- advanced breast cancer in combination with fulvestrant; It is the first drug to target PIK3CA mutations, which can effectively stop the growth of tumor cells.

How many versions of Alpelisib are there?

Alpelisib is currently available in several versions, including export versions from Laos, India and Hong Kong.

1. Laos Lucius version

150mg*28 tablets, the price is about 1755 yuan/box.

2. India export version

200mg*14 capsules and 150mg*28 capsules, the price is about 3900 yuan/box.

3. Hong Kong export version

150mg*56 capsules, the price is about 43,800 yuan/box.

These different versions of Alpelisib offer a variety of options for patients. After choosing the right version, the next step is to pay attention to the precautions when taking medication.

What are the precautions for taking Alpelisib?

There are some important considerations to be aware of before using Alpelisib to help better manage the treatment process.

1. Severe hypersensitivity

If the patient develops severe symptoms of hypersensitivity, such as rash, difficulty breathing, or facial swelling, Alpelisib must be discontinued immediately and used permanently. It is advisable to inform the patient on how to recognize these symptoms and seek immediate medical attention if they occur.

2. Pneumonia

If the patient develops new or worsening respiratory symptoms, particularly hypoxia, cough, or dyspnea, treatment with Alpelisib should be discontinued immediately and evaluated for pneumonia. Patients with confirmed non-infectious pneumonia should be permanently discontinued, and patients are advised to report any changes in respiratory symptoms promptly.

After understanding the precautions of Alpelisib, the next step is to pay attention to possible adverse effects and identify and deal with them early.

What are the adverse effects of Alpelisib?

When using Alpelisib, it is important to be aware of possible adverse effects.

1. Elevated glucose

Alpelisib may cause an increase in blood sugar levels, which requires close monitoring during treatment. Sometimes you may need to adjust your treatment regimen to control your blood sugar levels.

2. Creatinine is elevated

During treatment, some patients may experience elevated creatinine levels, which may be a sign of impaired renal function. Regular check-ups of renal function indicators are necessary.

Knowing about the common adverse effects of Alpelisib allows patients to better monitor and manage these side effects.

[Warm tips] During the use of Alpelisib, please have regular examinations and pay attention to possible adverse reactions. If you experience any discomfort or abnormal symptoms, please contact your doctor promptly.